June 27, 2011

PETRATOS et al v. GENENTECH, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 29, 2015

    Genentech Dodges FCA Claims Over Avastin's Side Effects

    A New Jersey federal judge on Thursday dismissed a False Claims Act against Genentech Inc. regarding its cancer drug Avastin, holding a whistleblower didn't show the drug's advertised claims were false and the Centers for Medicare & Medicaid Services and U.S. Food and Drug Administration properly approved the drug.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS